Speciality Medicines Limited (BOM:544738)

Market Cap	2.78B
Revenue (ttm)	582.71M +111.7%
Net Income	71.96M
EPS	11.18
Shares Out	8.79M
PE Ratio	28.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,000
Average Volume	79,250
Open	316.20
Previous Close	301.15
Day's Range	316.20 - 316.20
52-Week Range	121.10 - 381.20
Beta	n/a
RSI	73.82
Earnings Date	n/a

About Speciality Medicines

Speciality Medicines Limited engages in the manufacturing, marketing and distribution of finished formulations of specialty pharmaceutical products in India and internationally. The company offers tablets, capsules, cream, syrups, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, and suspension for oncology, immunology, neurology, and rare diseases therapeutic areas. It also provides patient, hospitals, institutions and NGO supplies, validated controlled supply m...

• Industry: Pharmaceutical Preparations
• Founded: 2021
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544738

Financial Performance

In fiscal year 2025, Speciality Medicines's revenue was 582.71 million, an increase of 111.71% compared to the previous year's 275.25 million. Earnings were 71.96 million, an increase of 77.62%.